Figure 50.
EDI-OCT measuring choroidal thickness in VKH disease. At presentation (a), mean subfoveolar thickness is increased to 502.6 µm. After introduction of steroidal and non-steroidal immunosuppression (b), thickness was reduced to 334.3 µm.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.